AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 187 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $42,694,000 | -17.9% | 925,121 | -1.9% | 0.03% | -16.7% |
| Q2 2021 | $51,990,000 | +2.0% | 943,378 | -4.4% | 0.04% | -5.3% |
| Q1 2021 | $50,978,000 | +19.2% | 987,188 | -0.0% | 0.04% | +15.2% |
| Q4 2020 | $42,779,000 | +12.4% | 987,278 | -9.2% | 0.03% | 0.0% |
| Q3 2020 | $38,055,000 | -34.6% | 1,087,278 | -0.0% | 0.03% | -37.7% |
| Q2 2020 | $58,164,000 | +50.8% | 1,087,579 | +0.0% | 0.05% | +26.2% |
| Q1 2020 | $38,580,000 | -25.4% | 1,087,379 | -0.0% | 0.04% | -2.3% |
| Q4 2019 | $51,696,000 | +25.3% | 1,087,883 | -14.5% | 0.04% | +19.4% |
| Q3 2019 | $41,242,000 | -44.5% | 1,272,905 | -14.5% | 0.04% | -43.8% |
| Q2 2019 | $74,250,000 | -27.3% | 1,488,578 | -1.7% | 0.06% | -28.9% |
| Q1 2019 | $102,149,000 | +47.3% | 1,514,658 | +0.7% | 0.09% | +28.6% |
| Q4 2018 | $69,362,000 | -40.3% | 1,504,273 | -0.2% | 0.07% | -30.0% |
| Q3 2018 | $116,194,000 | -8.4% | 1,506,662 | +0.0% | 0.10% | -3.8% |
| Q2 2018 | $126,904,000 | +1.5% | 1,506,642 | -1.4% | 0.10% | -11.9% |
| Q1 2018 | $124,993,000 | +43.0% | 1,528,408 | +0.0% | 0.12% | +45.7% |
| Q4 2017 | $87,379,000 | -14.4% | 1,528,398 | -0.0% | 0.08% | -17.3% |
| Q3 2017 | $102,054,000 | +29.3% | 1,528,895 | -0.3% | 0.10% | +25.6% |
| Q2 2017 | $78,910,000 | -12.2% | 1,533,715 | -0.3% | 0.08% | -13.3% |
| Q1 2017 | $89,872,000 | +40.0% | 1,538,912 | +0.0% | 0.09% | +26.8% |
| Q4 2016 | $64,216,000 | -16.7% | 1,538,839 | +5.5% | 0.07% | -18.4% |
| Q3 2016 | $77,051,000 | +25.9% | 1,458,751 | -0.1% | 0.09% | +20.8% |
| Q2 2016 | $61,178,000 | +13.7% | 1,460,275 | +10.2% | 0.07% | +12.5% |
| Q1 2016 | $53,783,000 | -37.0% | 1,324,699 | +0.7% | 0.06% | -35.4% |
| Q4 2015 | $85,374,000 | +284.1% | 1,315,060 | +317.6% | 0.10% | +266.7% |
| Q3 2015 | $22,227,000 | -27.2% | 314,878 | +14.6% | 0.03% | -15.6% |
| Q2 2015 | $30,548,000 | +17.5% | 274,862 | -0.3% | 0.03% | +18.5% |
| Q1 2015 | $26,004,000 | -15.9% | 275,763 | -0.1% | 0.03% | -18.2% |
| Q4 2014 | $30,926,000 | +83.2% | 276,030 | +0.3% | 0.03% | +73.7% |
| Q3 2014 | $16,877,000 | +33.9% | 275,100 | 0.0% | 0.02% | +35.7% |
| Q2 2014 | $12,605,000 | +17.0% | 275,100 | 0.0% | 0.01% | +7.7% |
| Q1 2014 | $10,770,000 | +65.7% | 275,100 | +1.4% | 0.01% | +62.5% |
| Q4 2013 | $6,498,000 | +32.6% | 271,320 | +54.8% | 0.01% | +14.3% |
| Q3 2013 | $4,899,000 | – | 175,220 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |